Table 2 Factors influencing neutralizing and anti-RBD antibody production in the elderly
Time points | Variables | OR (95% CI) | P value |
|---|---|---|---|
Neutralizing antibodies | |||
Month 2 | Underlying diseases: combine (vs not combine) | 0.228 (0.094–0.550) | 0.001 |
Month 7 | Age | 0.888 (0.815–0.967) | 0.007 |
Underlying diseases: combine (vs not combine) | 0.377 (0.167–0.849) | 0.019 | |
Anti-RBD antibodies | |||
Month 2 | Gender: female (vs male) | 2.576 (1.046–6.342) | 0.040 |
Underlying diseases: combine (vs not combine) | 0.361 (0.144–0.903) | 0.029 | |
Month 7 | Gender: female (vs male) | 2.653 (1.257–5.600) | 0.010 |
Underlying diseases: combine (vs not combine) | 0.398 (0.191–0.828) | 0.014 | |
